BRIVAHENZ 50mg Injection 5ml
Get notified when this medicine is available.
9M+ Happy Customers
100% Authentic
Quality Checked Products| ALTERNATE BRANDS |
Introduction About BRIVAHENZ 50MG INJECTION
BRIVAHENZ 50MG INJECTION is used to manage epilepsy. It contains Brivaracetam which belongs to the group of medicines called Anti-epileptics. It works by attaching itself to specific sites (SV2A) on the surfaces of nerve cells which suppresses the abnormal activity of the nerve cells in the brain and manages the spread of electrical signals that cause seizures.
Before taking BRIVAHENZ 50MG INJECTION inform your doctor if you have depression, self-harming thoughts, or any unusual changes in mood and behaviour. It is not recommended to use in patients with severe liver problems. It is generally not recommended to use in pregnancy and breastfeeding women. BRIVAHENZ 50MG INJECTION is not recommended for use in children under 4 years of age.
The most common side effects are feeling sleepy or dizzy, flu, feeling very tired, convulsion (a feeling of spinning), feeling and being sick and constipation, depression, anxiety, not being able to sleep, irritability, infection of nose and throat and decreased appetite. Contact your doctor if any of the symptoms worsen.
Uses Of BRIVAHENZ 50MG INJECTION
- Used in the management of epilepsy
How BRIVAHENZ 50MG INJECTION Works
Brivaracetam works by attaching itself to specific sites (SV2A) on the surfaces of nerve cells which suppresses the abnormal activity of the nerve cells in the brain and manages the spread of electrical signals that cause seizures.
How to use BRIVAHENZ 50MG INJECTION
- It must be given by a doctor or nurse into the veins as an intravenous infusion
- Your doctor will decide the correct dose and duration for you depending on your age, body weight, and disease condition
Side Effects Of BRIVAHENZ 50MG INJECTION
Common side effects of BRIVAHENZ 50MG INJECTION:
- feeling sleepy or dizzy
- flu
- feeling very tired (fatigue)
- convulsion, a feeling of ‘spinning’ (vertigo)
- constipation
- anxiety not being able to sleep (insomnia)
- irritability
- infection of the nose and throat, cough
- decreased appetite
- restlessness and hyperactivity (psychomotor hyperactivity)
- loss of touch with reality and/or abnormal thinking
- nervous excitement (agitation)
- decrease in white blood cells
- self-harming thoughts
Warning & Precautions
Pregnancy
Monitoring requiredBRIVAHENZ 50MG INJECTION is not recommended for use in pregnant women unless considered necessary.
Breastfeeding
ContraindicatedBRIVAHENZ 50MG INJECTION is not recommended for use in breastfeeding women as it may pass through breast milk.
Driving and Using Machines
Use with CautionDo not drive or operate any machines if you feel sleepy, dizzy, or tired while receiving the medicine.
Alcohol
Consult your doctorAvoid consumption of alcohol while receiving this medicine.
Kidney
ContraindicatedBRIVAHENZ 50MG INJECTION is not recommended for use in patients with impaired renal function.
Liver
Use with CautionBRIVAHENZ 50MG INJECTION should be taken with caution in patients with hepatic impairment.
Allergy
ContraindicatedDo not receive BRIVAHENZ 50MG INJECTION if you are allergic to Brivaracetam or any other ingredients of this medicine.
Use In Pediatrics
ContraindicatedBRIVAHENZ 50MG INJECTION is not recommended for use in children under 4 years of age.
Use In Geriatrics
Use with CautionBRIVAHENZ 50MG INJECTION should be used with caution in elderly patients (aged 65 years and above).
Others
Before taking the medicine, inform your doctor if you have:
- depression, self-harming thoughts or any unusual changes in mood and behaviour
Interactions
A. Drug-Drug interactions:
Before taking BRIVAHENZ 50MG INJECTION, inform your doctor if you are taking any of the following medicine:
- Antibiotics (Ex. rifampicin)
- St John’s wort (Ex. Hypericum perforatum)
Overdosage:
BRIVAHENZ 50MG INJECTION will be administered to you only by a doctor or a nurse in a hospital and it is so unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual problems.
Synopsis
| Drug | : | Brivaracetam |
| Pharmacological Category | : | Anti-epileptics |
| Therapeutic Indication | : | Epilepsy |
| Dosage Forms | : | Tablet, Injection, Oral solution, syrup |
FAQs About BRIVAHENZ 50MG INJECTION
Q: What is epilepsy?
A: Epilepsy is a chronic non-communicable disease of the brain, which affects around 50 million people worldwide. Epilepsy is characterized by recurrent seizures, which are small episodes of involuntary movement that may involve a part of the body (partial) or the entire body (generalized) and are sometimes associated with loss of consciousness and control of bowel or bladder function.
Q: Can I stop receiving BRIVAHENZ 50MG INJECTION if I start feeling better?
A: No. This medicine should not be stopped even if you start feeling better. Suddenly stopping the medicine may cause continuous seizures which can be difficult to control. You should consult your doctor who will advise you to discontinue the medicine gradually.
Q: BRIVAHENZ 50MG INJECTION can be used in children?
A: No. It is not recommended for use in children below 4 years of age.
Q: Can BRIVAHENZ 50MG INJECTION be given to nursing mothers?
A: No. It should not be used in nursing mothers as it is excreted through milk and can get transferred to the baby while breastfeeding.
Q: What precaution has to be taken if received more BRIVAHENZ 50MG INJECTION?
A: BRIVAHENZ 50MG INJECTION will be administered to you only by a doctor or a nurse in a hospital and it is so unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual problems.
Q: BRIVAHENZ 50MG INJECTION can be taken during hepatic impairment?
A: Caution should be taken while receiving BRIVAHENZ 50MG INJECTION if you have any liver disease.
References
1. Misty D. Smith, Cameron S. Metcalf, and Karen S. Wilcox. Pharmacotherapy of the Epilepsies. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 13th Edition. New York McGraw Hill Medical 2018 Page – 303-326.
2. Felix Zahnert, Kristina Krause, Ilka Immisch, Lena Habermehl, Iris Gorny, Izabella Chmielewska, Leona Möller, Anna M. Weyand, Peter M. Mross, Jan Wagner, Katja Menzler and Susanne Knake. Brivaracetam in the Treatment of Patients with Epilepsy - First Clinical Experiences. Journal of Frontiers in neurology. February 2018. [Accessed on 2nd May 2022] click here
3. Farbod Khaleghi, and Eric C. Nemec. A Novel Adjunctive Therapy for Partial-Onset Seizures. February 2017. [Accessed on 2nd May 2022] click here
4. UCB Pharma limited. Electronic Medicines Compendium (EMC). [Revised in October 2021] [Accessed 2nd May 2022] click here
User Feedback
Author Details
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.
